Edinburgh Royal Infirmary

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 3	2026-10-07	NCT07775300
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder	Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder	Recruiting	Phase 3	2026-10-07	NCT07219966
A Study of Brenipatide in Adult Participants With Major Depressive Disorder	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 3	2026-10-05	NCT07412756
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)	Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, type 2 diabetes mellitus, urinary system disorder	Active, not recruiting	Phase 3	2026-07-20	NCT06297603

Clinical trials